Organogenesis Holdings Inc.
ORGO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661181
No open-market purchases or sales by Organogenesis Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $160.4M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Organogenesis Holdings Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 132 | 113 | −19 |
| Shares | 53.3M | 51.8M | −1.56M (−2.9%) |
| Value | $113.8M | $171.8M | +$58.0M (+51.0%) |
New holders (14)
Institutions that held Organogenesis Holdings Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,240,594 | $4.12M | 0.08% |
| Shay Capital LLC | 150,000 | $498.0K | 0.18% |
| Thompson Siegel & Walmsley LLC | 118,952 | $395.0K | 0.01% |
| Occudo Quantitative Strategies LP | 76,549 | $254.1K | 0.03% |
| G2 Investment Partners Management LLC | 60,634 | $201.3K | 0.05% |
| Algert Global LLC | 24,205 | $80.4K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 22,596 | $75.0K | 0.01% |
| State Board of Administration of Florida Retirement System | 19,940 | $66.2K | 0.00% |
| Centiva Capital, LP | 18,595 | $61.7K | 0.00% |
| Quantbot Technologies LP | 17,682 | $58.7K | 0.00% |
| Schonfeld Strategic Advisors LLC | 17,000 | $56.4K | 0.00% |
| Cresset Asset Management, LLC | 11,027 | $36.6K | 0.00% |
| Great Lakes Advisors, LLC | 10,585 | $35.1K | 0.00% |
| Metropolitan Life Insurance Co | 3,961 | $13.2K | 0.00% |
Sold out (33)
Institutions that held Organogenesis Holdings Inc. at the end of Q1 2023 and filed for Q2 2023 without it.